Literature DB >> 19324102

A 9.3 Mb microdeletion of 3q27.3q29 associated with psychomotor and growth delay, tricuspid valve dysplasia and bifid thumb.

M Pollazzon1, S Grosso, F T Papa, E Katzaki, A Marozza, M A Mencarelli, V Uliana, P Balestri, F Mari, A Renieri.   

Abstract

We describe a de novo 3q27.3q29 deletion in a 2.5-year-old female patient with developmental and growth delay, dysmorphic facial features, mild tricuspid valve dysplasia, bifid thumb, clinodactyly of the 2nd toe bilaterally and scoliosis. The deletion overlaps for about 1Mb with the 1.6Mb region commonly deleted in patients with 3q29 microdeletion syndrome. The phenotype of the two syndromes is not completely overlapping, though the most important clinical features, such as mental retardation and microcephaly, occur in both. This suggests that the deletion in our patient causes a distinct clinical phenotype, not described previously. In the deleted region there are 47 annotated genes. Among them, seven are of particular interest for correlation with clinical features of the patient. Two genes, OPA1 and CCDC50, responsible for autosomal dominant optic atrophy and deafness, respectively, may be important for the correct follow-up of the patient.

Entities:  

Mesh:

Year:  2009        PMID: 19324102     DOI: 10.1016/j.ejmg.2009.03.009

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  4 in total

1.  A case of 3q29 microdeletion syndrome involving oral cleft inherited from a nonaffected mosaic parent: molecular analysis and ethical implications.

Authors:  Aline L Petrin; Sandra Daack-Hirsch; Jamie L'Heureux; Jeffrey C Murray
Journal:  Cleft Palate Craniofac J       Date:  2010-05-04

2.  The 3q29 microdeletion syndrome: report of three new unrelated patients and in silico "RNA binding" analysis of the 3q29 region.

Authors:  Majed J Dasouki; Gerald H Lushington; Karine Hovanes; James Casey; Mereceds Gorre
Journal:  Am J Med Genet A       Date:  2011-05-27       Impact factor: 2.802

3.  HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395.

Authors:  Guoliang Sun; Hui Zhou; Ke Chen; Jin Zeng; Yangjun Zhang; Libin Yan; Weimin Yao; Junhui Hu; Tao Wang; Jinchun Xing; Kefeng Xiao; Lily Wu; Zhangqun Ye; Hua Xu
Journal:  J Exp Clin Cancer Res       Date:  2020-06-19

4.  Genotype-phenotype association and variant characterization in Diamond-Blackfan anemia caused by pathogenic variants in RPL35A.

Authors:  Matthew D Gianferante; Marcin W Wlodarski; Evangelia Atsidaftos; Lydie Da Costa; Polyxeni Delaporta; Jason E Farrar; Frederick D Goldman; Maryam Hussain; Antonis Kattamis; Thierry Leblanc; Jeffrey M Lipton; Charlotte M Niemeyer; Dagmar Pospisilova; Paola Quarello; Ugo Ramenghi; Vijay G Sankaran; Adrianna Vlachos; Jana Volejnikova; Blanche P Alter; Sharon A Savage; Neelam Giri
Journal:  Haematologica       Date:  2021-05-01       Impact factor: 9.941

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.